Background: Patent ductus arteriosus (PDA) is a dramatically harmful disease in the neonatal period, in particular common in preterm infants, and our study was to determine related factors of PDA in ...

Cite this: Current Controversies in the Diagnosis and Treatment of Patent Ductus Arteriosus in Preterm Infants - Medscape - Aug 01, 2003. The DA of a very preterm infant has minimal constriction ...

COPENHAGEN, Jan 15 (Reuters) - Finland's Nokia (NOKIA.HE), opens new tab said on Wednesday it had signed a multi-year patent license agreement with Samsung (005930.KS), opens new tab, for the use ...

Objective To compare the efficacy and safety of oral versus intravenous ibuprofen for the pharmacological closure of patent ductus arteriosus (PDA) in less mature preterm infants. Design Prospective, ...

Samsung Electronics Co., Ltd. affirming a final written decision by the Patent Trial and Appeal Board (PTAB) that invalidated Lynk Lab’s patent claims to alternating current driven LED lights ...

Jan 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to ...

(By comparison, the last major patent cliff that hit the industry, in 2011, jeopardized around $250 billion in drug revenue.) One of the few tried-and-tested methods for navigating a patent ...

Pfizer saved $4 billion, plans $1.5 billion more in margin improvements, and issued $7 billion in dividends in nine months. Acquisitions are projected to offset $17 billion-18 billion in revenue ...

The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ... and the Orange Book Transparency Act of ...

Leadership transparency will be key to organizational success in 2025. Many organizations still struggle to build trust with their employees, especially during confusing return-to-office policies.